During the past decade, Toho University Sakura Medical Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 15 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 13 clinical trials were completed. i.e. 108.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toho University Sakura Medical Center" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Shire" with 5 trials sponsored, "Pfizer" with 4 trials sponsored and "Galapagos NV" with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toho University Sakura Medical Center" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Toho University Sakura Medical Center" are "Ulcerative Colitis" (12 trials), "Crohn's Disease" (8 trials), "Prostatic Neoplasms" (5 trials), "Psoriasis" (2 trials) and "Abiraterone Acetate" (1 trials). Many other conditions were trialed in "Toho University Sakura Medical Center" in a lesser frequency.

Most popular intervention types in "Toho University Sakura Medical Center" are "Drug" (32 trials), "Biological" (6 trials), "Other" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Filgotinib" (4 trials), "Guselkumab" (4 trials), "Mirikizumab" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Toho University Sakura Medical Center" are 28 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Toho University Sakura Medical Center". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Toho University Sakura Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Toho University Sakura Medical Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".